| The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication EC Clarke, RA Nofchissey, C Ye, SB Bradfute Glycobiology 31 (4), 378-384, 2021 | 55 | 2021 |
| Human colonoid monolayers to study interactions between pathogens, commensals, and host intestinal epithelium JG In, J Foulke-Abel, E Clarke, O Kovbasnjuk JoVE (Journal of Visualized Experiments), e59357, 2019 | 45 | 2019 |
| Comparison of N-and O-linked glycosylation patterns of ebolavirus glycoproteins AL Collar, EC Clarke, E Anaya, D Merrill, S Yarborough, SM Anthony, ... Virology 502, 39-47, 2017 | 35 | 2017 |
| The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: Potential effects on adaptive immunity and … EC Clarke, SB Bradfute Antiviral research 174, 104703, 2020 | 18 | 2020 |
| Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus P Hraber, S Bradfute, E Clarke, C Ye, B Pitard Vaccine 36 (46), 6911-6917, 2018 | 18 | 2018 |
| Production and purification of filovirus glycoproteins in insect and mammalian cell lines EC Clarke, AL Collar, C Ye, Y Caì, E Anaya, D Rinaldi, B Martinez, ... Scientific reports 7 (1), 15091, 2017 | 16 | 2017 |
| Ambroxol and ciprofloxacin show activity against SARS-CoV2 in Vero E6 cells at clinically-relevant concentrations SB Bradfute, C Ye, EC Clarke, S Kumar, GS Timmins, V Deretic bioRxiv, 2020 | 13 | 2020 |
| Generation and selection of a panel of pan-filovirus single-chain antibodies using cell-free ribosome display A Kunamneni, EC Clarke, C Ye, SB Bradfute, R Durvasula The American Journal of Tropical Medicine and Hygiene 101 (1), 198, 2019 | 6 | 2019 |
| A method for mapping the linear epitopes targeted by the natural antibody response to Zika virus infection using a VLP platform technology A Fowler, C Ye, EC Clarke, JM Pascale, DS Peabody, SB Bradfute, ... Virology 579, 101-110, 2023 | 3 | 2023 |
| Advances in Ebola virus vaccination EC Clarke, SB Bradfute The Lancet Infectious Diseases 17 (8), 787-788, 2017 | 3 | 2017 |
| Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono-and multi-valent adjuvanted glycoprotein vaccines J Felgner, E Clarke, JE Hernandez-Davies, S Jan, AS Wirchnianski, ... Antiviral Research 225, 105851, 2024 | | 2024 |
| Considerations for Glycoprotein Production EC Clarke Recombinant Glycoproteins: Methods and Protocols, 329-351, 2024 | | 2024 |
| Effects of Passive Immunization on Immunogenicity of Filovirus Vaccines EC Clarke, C Ye, R Nofchissey, SB Bradfute, ... | | 2021 |
| The impact of glycoyslation on filovirus vaccine immunogenicity in mice EC Clarke, S Bradfute The Journal of Immunology 204 (1_Supplement), 247.20-247.20, 2020 | | 2020 |
| THE EFFECTS OF GLYCOSYLATION ON IMMUNOGENICITY AND REPLICATION OF EMERGING VIRAL PATHOGENS EC Clarke | | 2020 |
| permissions, please e-mail: journals. permissions@ oup. com EC Clarke, RA Nofchissey, C Ye, SB Bradfute | | 2020 |
| Ambroxol and Ciprofloxacin Show Activity Against SARS-CoV2 in Vero E6 Cells at Clinically-Relevant Concentrations GS Timmins, SB Bradfute, V Deretic, S Kumar, EC Clarke, C Ye | | 2020 |
Steven BradfuteUniversity of New MexicoVerified email at salud.unm.edu
